Type 1 diabetes in adults: diagnosis and management - NICE This guideline updates and replaces NICE technology appraisal guidance 53 and 60 and NICE evidence summaries ESNM24 and ESNM62 It also partially updates and replaces NICE guideline CG15 (published July 2004) Recommendations This guideline includes recommendations on: Diagnosis and early care plan; Support and individualised care
Type 1 diabetes in adults: diagnosis and management - NICE Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards
NG17 Type 1 diabetes in adults: diagnosis and management - NICE This guideline will update NICE guideline NG17 (published August 2015) Who is it for? • Healthcare professionals • Commissioners and providers • Adults with type 1 diabetes and their families and carers What does it include? • the draft recommendations • recommendations for research
Type 1 diabetes in adults: diagnosis and management - NICE Continuous subcutaneous insulin infusion (insulin pump) therapy is recommended as an option in NICE technology appraisal guidance for treating some adults with type 1 diabetes For full details, see the guidance on continuous subcutaneous insulin infusion (TA151, 2008)
NG17 Type 1 diabetes in adults: diagnosis and management - NICE Type 1 diabetes in adults: NICE guideline DRAFT (November 2021) 7 of 21 • Whether the person has situations when symptoms of hypoglycaemia cannot be communicated or can be confused, for example during exercise • Clinical factors that may make devices easier or harder to use • Frequency of sensor replacement